CoChat

High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S.

Open access
Nelson, Adam J., Haynes, Kevin, Shambhu, Sonali, Eapen, Zubin, Cziraky, Mark J., Nanna, Michael G., Calvert, Sara B., Gallagher, Kerrin, Pagidipati, Neha J., Granger, Christopher B. · 2022 · Journal of the American College of Cardiology
Cited by 153

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

Background: Preventive therapy among patients with established atherosclerotic cardiovascular disease (ASCVD) is generally underused. Whether new guideline recommendations and a focus on implementation have improved the use of high-intensity statins is unknown. Objectives: To evaluate the patterns and predictors of statin use among patients with ASCVD. Methods: In this retrospective cohort study, pharmacy and medical claims data from a commercial health plan were queried for patients with established ASCVD between 31st January 2018 and 31st January 2019. Statin use on an index date of 31st January 2019 was evaluated, as was 12-month adherence and discontinuation. Multivariable logistic regression was used to determine independent associations with varying intensity statin use. Results: Of the 601 934 patients with established ASCVD, 41.7% were female, mean age 67.5±13.3. Overall, 22.5% of the cohort were on a high-intensity statin, 27.6% were on low- or moderate-intensity statin, and 49.9% were not on any statin. In multivariable analysis, younger patients, females and those with higher Charlson comorbidity were less likely to be prescribed any statin. Among statin users, females, older patients and those with peripheral artery disease were less likely to be on a high-intensity formulation, while a cardiology encounter in the prior year increased the odds. The majority of high-intensity stain users achieved high levels of adherence. Conclusions: Substantial underuse of statins persists in a large, insured and contemporary cohort of patients with ASCVD from the United States. In particular, concerning gaps in appropriate statin use remain among younger patients, women and those with non-coronary ASCVD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2022.02.048

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 153

Metadata

Authors
Nelson, A. J., Haynes, K., Shambhu, S., Eapen, Z., Cziraky, M. J., Nanna, M. G., Calvert, S. B., Gallagher, K., Pagidipati, N. J., & Granger, C. B.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2022-05
Volume
79
Issue
18
Pages
1802-1813
ISSN
0735-1097 (ISSN-L)
OpenAlex
W4225286222
Cited by
153
References
21
FWCI
27.13
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S. https://app.cochat.ai/papers/10.1016/j.jacc.2022.02.048
The paper
Nelson, A. J., Haynes, K., Shambhu, S., Eapen, Z., Cziraky, M. J., Nanna, M. G., Calvert, S. B., Gallagher, K., Pagidipati, N. J., & Granger, C. B. (2022). High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2022.02.048

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.